Benjamin F. Edwards & Company Inc. cut its stake in Clorox Company (The) (NYSE:CLX) by 4.5% during the second quarter, Holdings Channel reports. The firm owned 10,052 shares of the company’s stock after selling 477 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Clorox Company (The) were worth $1,339,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. increased its position in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after buying an additional 9,698,542 shares during the last quarter. Parnassus Investments CA bought a new position in shares of Clorox Company (The) during the first quarter worth approximately $434,255,000. Vanguard Group Inc. increased its position in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares during the last quarter. Morgan Stanley increased its position in shares of Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock worth $134,342,000 after buying an additional 241,210 shares during the last quarter. Finally, WINTON GROUP Ltd increased its position in shares of Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock worth $28,566,000 after buying an additional 201,737 shares during the last quarter. 70.29% of the stock is currently owned by institutional investors and hedge funds.
Shares of Clorox Company (CLX) opened at 135.50 on Tuesday. The firm has a market capitalization of $17.45 billion, a PE ratio of 26.77 and a beta of 0.40. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The firm has a 50-day moving average of $134.79 and a 200-day moving average of $133.07.
Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period last year, the business earned $1.30 EPS. On average, equities research analysts anticipate that Clorox Company will post $5.68 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Benjamin F. Edwards & Company Inc. Has $1.34 Million Stake in Clorox Company (The) (NYSE:CLX)” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://stocknewstimes.com/2017/08/08/benjamin-f-edwards-company-inc-has-1-34-million-stake-in-clorox-company-the-nyseclx.html.
A number of brokerages recently commented on CLX. UBS AG reaffirmed a “sell” rating and set a $121.00 price objective (up from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th. BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. BMO Capital Markets set a $150.00 price objective on shares of Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Zacks Investment Research downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $129.13.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
